The clinical applicability of our findings is emphasized by the potential for monitoring BMI or CRP levels in patients with osteoarthritis, as this strategy could assist in preventing complications associated with the comorbidity of osteoarthritis and chronic pancreatitis. This evidence concerns the gene CRP and chronic pancreatitis.